S5524 When the Liver Lies: A Rare Presentation of Primary Hepatic Gastrinoma

Introduction: Zollinger-Ellison Syndrome (ZES) is caused by gastrin-secreting neuroendocrine tumors most commonly originating in the pancreas or duodenum. The liver is a frequent site of metastasis, but primary hepatic gastrinomas are exceedingly rare, with fewer than 30 cases reported. Distinguishing primary hepatic gastrinoma from metastatic disease is critical, as complete surgical resection can be curative. Case Description/Methods: A 34-year-old woman with no significant past medical history presented with right upper quadrant abdominal pain that began the night prior. Pain did not radiate to the shoulders or back and had no clear food-related triggers. She denied fever, chills, constipation, diarrhea, or any history of abdominal surgeries. Abd ultrasound showed a 9.8 × 6.5 cm solid lesion in the right hepatic lobe. Computed tomography showed a heterogeneously enhancing mass in the same region, concerning a malignant neoplasm. A liver biopsy confirmed a well-differentiated neuroendocrine tumor, WHO grade 2. Subsequent workup, including EGD, endoscopic ultrasound (EUS), and fine needle aspiration (FNA) biopsies, showed no evidence of a primary lesion in the gastrointestinal tract. Gastrin levels were elevated over 700 pg/mL. Enteroscopy demonstrated scattered erosions throughout the duodenum and proximal jejunum, along with deeper ulcerations and edema in the third part of the duodenum, consistent with ZES. EUS failed to identify a primary tumor, and FNA of peripancreatic lymph nodes was benign. To prepare for surgical resection, the patient underwent right portal vein embolization to promote hypertrophy of the left liver. She then underwent a robotic right hepatectomy to remove the hepatic neuroendocrine tumor. Two months postoperatively, repeat enteroscopy showed healed duodenal ulcers with mild, non-obstructive luminal narrowing and mucosal scarring in the third portion of the duodenum. No active inflammation was observed, and her gastrin levels had normalized. This case represents an extremely rare instance of a primary hepatic neuroendocrine tumor. Discussion: This case highlights an extremely rare presentation of primary hepatic gastrinoma resulting in Zollinger-Ellison syndrome. The absence of an extrahepatic primary tumor despite extensive imaging and endoscopic evaluation, combined with postoperative normalization of gastrin levels and symptom resolution, supports the liver lesion as the primary source. This case emphasizes the importance of a comprehensive diagnostic approach and suggests that, when confirmed, surgical resection can be curative in primary hepatic gastrinoma.

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001149556.28077.f3
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S5524 When the Liver Lies: A Rare Presentation of Primary Hepatic Gastrinoma

The American Journal of Gastroenterology
Neuroendocrine Tumor Research Advances
article

S5524 When the Liver Lies: A Rare Presentation of Primary Hepatic Gastrinoma

article en

Abstract

Introduction: Zollinger-Ellison Syndrome (ZES) is caused by gastrin-secreting neuroendocrine tumors most commonly originating in the pancreas or duodenum. The liver is a frequent site of metastasis, but primary hepatic gastrinomas are exceedingly rare, with fewer than 30 cases reported. Distinguishing primary hepatic gastrinoma from metastatic disease is critical, as complete surgical resection can be curative. Case Description/Methods: A 34-year-old woman with no significant past medical history presented with right upper quadrant abdominal pain that began the night prior. Pain did not radiate to the shoulders or back and had no clear food-related triggers. She denied fever, chills, constipation, diarrhea, or any history of abdominal surgeries. Abd ultrasound showed a 9.8 × 6.5 cm solid lesion in the right hepatic lobe. Computed tomography showed a heterogeneously enhancing mass in the same region, concerning a malignant neoplasm. A liver biopsy confirmed a well-differentiated neuroendocrine tumor, WHO grade 2. Subsequent workup, including EGD, endoscopic ultrasound (EUS), and fine needle aspiration (FNA) biopsies, showed no evidence of a primary lesion in the gastrointestinal tract. Gastrin levels were elevated over 700 pg/mL. Enteroscopy demonstrated scattered erosions throughout the duodenum and proximal jejunum, along with deeper ulcerations and edema in the third part of the duodenum, consistent with ZES. EUS failed to identify a primary tumor, and FNA of peripancreatic lymph nodes was benign. To prepare for surgical resection, the patient underwent right portal vein embolization to promote hypertrophy of the left liver. She then underwent a robotic right hepatectomy to remove the hepatic neuroendocrine tumor. Two months postoperatively, repeat enteroscopy showed healed duodenal ulcers with mild, non-obstructive luminal narrowing and mucosal scarring in the third portion of the duodenum. No active inflammation was observed, and her gastrin levels had normalized. This case represents an extremely rare instance of a primary hepatic neuroendocrine tumor. Discussion: This case highlights an extremely rare presentation of primary hepatic gastrinoma resulting in Zollinger-Ellison syndrome. The absence of an extrahepatic primary tumor despite extensive imaging and endoscopic evaluation, combined with postoperative normalization of gastrin levels and symptom resolution, supports the liver lesion as the primary source. This case emphasizes the importance of a comprehensive diagnostic approach and suggests that, when confirmed, surgical resection can be curative in primary hepatic gastrinoma.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 32%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.